Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.09 - $6.0 $655 - $1,272
-212 Reduced 0.85%
24,753 $132,000
Q4 2023

Feb 13, 2024

SELL
$1.57 - $4.58 $158 - $462
-101 Reduced 0.4%
24,965 $106,000
Q3 2023

Nov 13, 2023

BUY
$3.14 - $11.2 $2,797 - $9,979
891 Added 3.69%
25,066 $98,000
Q2 2023

Aug 04, 2023

BUY
$8.45 - $12.48 $51,798 - $76,502
6,130 Added 33.97%
24,175 $244,000
Q1 2023

May 12, 2023

BUY
$9.21 - $14.98 $3,315 - $5,392
360 Added 2.04%
18,045 $184,000
Q4 2022

Feb 10, 2023

SELL
$8.57 - $17.0 $548 - $1,088
-64 Reduced 0.36%
17,685 $165,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $17.54 $3,140 - $4,385
250 Added 1.43%
17,749 $258,000
Q2 2022

Aug 12, 2022

BUY
$10.55 - $18.81 $62,044 - $110,621
5,881 Added 50.62%
17,499 $231,000
Q1 2022

May 13, 2022

SELL
$11.67 - $26.72 $4,049 - $9,271
-347 Reduced 2.9%
11,618 $198,000
Q4 2021

Feb 11, 2022

BUY
$13.77 - $42.56 $164,758 - $509,230
11,965 New
11,965 $307,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.